Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus
Objective: Diabetes mellitus (DM) is one of the risks linked with susceptibility of thrombosis.
We tried to inspect the effect of a novel oral antidiabetic agent, vildagliptin, in preventing …
We tried to inspect the effect of a novel oral antidiabetic agent, vildagliptin, in preventing …
Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus.
S Khan, BP Panda, M Akhtar… - Expert Opinion on …, 2015 - europepmc.org
Objective Diabetes mellitus (DM) is one of the risks linked with susceptibility of thrombosis.
We tried to inspect the effect of a novel oral antidiabetic agent, vildagliptin, in preventing …
We tried to inspect the effect of a novel oral antidiabetic agent, vildagliptin, in preventing …
Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus
S Khan, S Khan, BP Panda… - Expert opinion on …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective Diabetes mellitus (DM) is one of the risks linked with susceptibility of thrombosis.
We tried to inspect the effect of a novel oral antidiabetic agent, vildagliptin, in preventing …
We tried to inspect the effect of a novel oral antidiabetic agent, vildagliptin, in preventing …